Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

SmithKline Beecham's Androderm now available as a single patch system

May 7, 1997

Positive clinical results for amylin analogue in diabetes

May 7, 1997

Combined blockade of 5-HT1A and 5-HT1B receptors potentiates fluoxetine activity

May 7, 1997

Neuromyalgic response to rhNGF described

May 6, 1997

Rhone-Poulenc Rorer licenses Granocyte for additional countries

May 6, 1997

AGM-1470 may have potential for controlling fertility

May 6, 1997

Squalene synthase inhibitors reported by Takeda

May 6, 1997

Pfizer's CP-148623 lowers serum cholesterol in humans

May 6, 1997

BTS-67582 in diabetes

May 5, 1997

Hypolipidemic triterpenes claimed by Leo

May 5, 1997

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...